Gonadotropin-releasing hormone agonists (GnRH) are first line treatment for metastatic PCa and are also widely used in conjunction with radiotherapy in locally advanced PCa as both neoadjuvant and adjuvant therapy [4]. This evidence concerns the gene GNRH1 and posterior cortical atrophy.